# Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT)

> **NCT05136703** · NA · RECRUITING · sponsor: **Florida International University** · enrollment: 150 (estimated)

## Conditions studied

- Depression
- HIV-1-infection
- Inflammation

## Interventions

- **BEHAVIORAL:** Cognitive-Behavioral Therapy for Adherence and Depression (CBT-AD)
- **BEHAVIORAL:** Antiretroviral Therapy (ART) Adherence Counseling

## Key facts

- **NCT ID:** NCT05136703
- **Lead sponsor:** Florida International University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-08-30
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-12-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-02-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05136703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05136703, "Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05136703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*